NPS CEO succession
Executive Summary
N. Anthony Coles will succeed Hunter Jackson as NPS Pharmaceuticals CEO in six months. In the interim, he will serve in the new position of president and chief operating officer at the Salt Lake City-based company. Following the transition period, Jackson, who founded the company in 1986, will stay on as a director. Coles had been senior VP-commercial operations for Vertex Pharmaceuticals. He also previously held positions in the cardiovascular franchises of Bristol-Myers Squibb and Merck...